SCHEMBL5516014

SCHEMBL5516014

NC(=O)c1sc2ncccc2c1-c1ccccc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LIMK1 P53667 3/20 0.66
IKBKB O14920 1/20 0.66
CHUK O15111 1/20 0.66
ALDH1A1 P00352 4/20 0.49
KDM4E B2RXH2 2/20 0.49
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49
NPC1 O15118 1/20 0.48
RAB9A P51151 1/20 0.48
MAP2 P11137 1/20 0.44
HTT P42858 2/20 0.44
HPGD P15428 1/20 0.44
ALOX15 P16050 1/20 0.44
TSHR P16473 1/20 0.44
MAPK1 P28482 1/20 0.44
HSD17B10 Q99714 1/20 0.44
BCAT2 O15382 1/20 0.44
LMNA P02545 1/20 0.43
PLA2G1B P04054 1/20 0.43
ATG4B Q9Y4P1 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5531760 0.90 LIMK1 (0.64) LIMK1IKBKBCHUKALDH1A1KDM4E
SCHEMBL5529444 0.87 LIMK1 (0.61) LIMK1IKBKBCHUKALDH1A1KDM4E
SCHEMBL8240403 0.83 KDM4E (0.48) LIMK1IKBKBCHUKALDH1A1KDM4E
SCHEMBL13605637 0.81 KDM4E (0.52) LIMK1IKBKBCHUKALDH1A1KDM4E
SCHEMBL5648903 0.81 KDM4E (0.53) ALDH1A1KDM4EMEN1KMT2ANPC1
SCHEMBL13605639 0.80 PADI4 (0.49) ALDH1A1KDM4EKMT2ANPC1RAB9A
SCHEMBL4356230 0.80 IKBKB (1.00) LIMK1IKBKBCHUKALDH1A1KDM4E
SCHEMBL4533208 0.78 KDM4E (0.49) LIMK1IKBKBCHUKALDH1A1KDM4E
SCHEMBL20723069 0.78 LIMK1 (0.69) LIMK1IKBKBCHUKALDH1A1KDM4E
SCHEMBL11341595 0.78 LIMK1 (0.69) LIMK1IKBKBCHUKALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070082880-A1 Thieno [2,3-B] pyridine-5-carbonitriles as protein kinase inhibitors WYETH 2007-04-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070082880-A1 Thieno [2,3-B] pyridine-5-carbonitriles as protein kinase inhibitors MAP4K2, CNKSR1, MAP3K1 LIMK1 1108/4885IKBKB 243/4885CHUK 48/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.